SERES THERAPEUT. DL -,001SERES THERAPEUT. DL -,001SERES THERAPEUT. DL -,001

SERES THERAPEUT. DL -,001

No trades
See on Supercharts

Price target

3.140.000.00%
The 4 analysts offering 1 year price forecasts for 1S9 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to 1S9 in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


1S9 EPS for the last quarter is 0.52 EUR despite the estimation of −0.07 EUR. In the next quarter EPS is expected to reach −0.19 EUR. Track more of SERES THERAPEUT. DL -,001 financials and stay on top of what is up with the company.
In the next quarter SERES THERAPEUT. DL -,001 revenue is expected to reach 0.00 EUR. Check out SERES THERAPEUT. DL -,001 revenue and earnings and make informed decisions.
According to analysts, 1S9 price target is 3.14 EUR with a max estimate of 9.47 EUR and a min estimate of 0.95 EUR. Check if this forecast comes true in a year, meanwhile watch SERES THERAPEUT. DL -,001 stock price chart and keep track of the current situation with 1S9 news and stock market news.
We've gathered opinions of 8 analysts rating 1S9 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.